Investors Who Lost Money With Shares of Moderna, Inc. (NASDAQ:MRNA) Should Contact the Shareholders Foundation in Connection With Lawsuit
SAN DIEGO, CA, August 16, 2024 (Newswire.com) - A lawsuit was filed for certain investors in shares of Moderna, Inc. (NASDAQ:MRNA). NASDAQ: MRNA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Moderna, Inc. (NASDAQ:MRNA).
Investors that purchased Moderna, Inc. (NASDAQ: MRNA) have certain options and for certain investors are short and strict deadlines running. Deadline: October 8, 2024. NASDAQ: MRNA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 09, 2024, a lawsuit was filed by an investor in NASDAQ: MRNA shares against Moderna, Inc. over alleged securities laws violations. The plaintiff alleged that Defendants made false and/or misleading statements and/or failed to disclose that mRNA-1345 was less effective than Defendants had led investors to believe, that accordingly, mRNA-1345's clinical and/or commercial prospects were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased Moderna, Inc. (NASDAQ: MRNA) shares should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact Information
Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554
SOURCE: Shareholders Foundation, Inc.
Source: Shareholders Foundation, Inc.
Related Media
